{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:21:31Z","timestamp":1791228091835,"version":"4.1.0"},"reference-count":0,"publisher":"Oxford University Press (OUP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2000,3,1]]},"DOI":"10.1093\/jnci\/92.5.376","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T18:25:57Z","timestamp":1027707957000},"page":"376-387","source":"Crossref","is-referenced-by-count":354,"title":["Preclinical and Clinical Development of Cyclin-Dependent Kinase Modulators"],"prefix":"10.1093","volume":"92","author":[{"given":"A. M.","family":"Senderowicz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","container-title":["Journal of the National Cancer Institute"],"original-title":[],"link":[{"URL":"http:\/\/academic.oup.com\/jnci\/article-pdf\/92\/5\/376\/8198996\/376.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,24]],"date-time":"2017-08-24T23:49:29Z","timestamp":1503618569000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jnci\/article-lookup\/doi\/10.1093\/jnci\/92.5.376"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,3,1]]},"references-count":0,"journal-issue":{"issue":"5"},"URL":"https:\/\/doi.org\/10.1093\/jnci\/92.5.376","relation":{},"ISSN":["1460-2105"],"issn-type":[{"value":"1460-2105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,3,1]]}}}